XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2023
EARNINGS PER SHARE  
EARNINGS PER SHARE

(8)   EARNINGS PER SHARE

Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding and the number of dilutive potential common share equivalents during the period. Dilution resulting from stock-based compensation plans is determined using the treasury stock method and dilution resulting from the 2023 Convertible Senior Notes is determined using the if-converted method. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential common shares outstanding would be anti-dilutive.

The calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2023 and 2022 are as follows (in thousands, except per share data):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

    

Basic earnings per share

 

  

 

  

 

  

 

  

 

Net income

$

3,594

$

4,873

$

8,517

$

9,596

Basic weighted average shares outstanding

 

35,531

 

38,046

 

36,216

 

38,881

Basic earnings per share

$

0.10

0.13

0.24

0.25

Diluted earnings per share

 

  

 

  

 

  

 

  

Net income

$

3,594

4,873

8,517

9,596

Weighted average shares outstanding

 

35,531

 

38,046

 

36,216

 

38,881

Effect of dilutive securities - options and restricted stock

 

572

 

819

 

650

 

848

Diluted weighted-average shares outstanding

 

36,103

 

38,865

 

36,866

 

39,729

Diluted earnings per share

$

0.10

0.13

$

0.23

$

0.24

For the three and nine months ended September 30, 2023, equity grants of 92,000 and 34,000 shares of common stock, respectively, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive.

For the three and nine months ended September 30, 2022, equity grants of 6,000 and 22,000 shares of common stock, respectively, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive.

For the three and nine months ended September 30, 2023, conversion options to purchase 5.6 million and 3.0 million shares, respectively, resulting from the 2023 Convertible Senior Notes, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive (see Note 10 – Convertible Senior Notes).